Going into Rx - Must I go to business school eventually?

So I am gonna be joining a top rx shop post grad (think PJT, HL, EVR, LAZ) and I am probably looking to continue a career in distressed investing (PE or HF) as it seems really interesting and exciting while providing a much more complex skillset that would allow me to transition back into traditional HF/PE work if I really wanted to leave that world. I kinda want to avoid business school if possible because it just seems like a really expensive 2 year vacation (just my opinion, wtf do i know) plus I have taken a couple of MBA classes as an undergrad. I really would just like to continue working.

The real question is if I will be pushed to go get an MBA by the firm I work at. I'm sure that at larger 'megafund' types that do distressed (Blackstone, Apollo and the like) most of the associates are definitely incentivized to go get an MBA but what about at some of the firms in the space that are less visible in the public eye (GoldenTree, Canyon, Crescent, Silver Point etc)? A quick LinkedIn search tells me a good portion of the individuals working at these firms do eventually go off to get MBAs, but are they likely to loosen their stance on MBAs in the future? I just don't really see why after a few years of picking up such a niche and detailed skill-set why business school would provide any value-add apart from appeasing LPs lol.

4 Comments
 

Understood, but in addition to not knowing where you'll be in 3 years, you can't really predict how you're going to feel about your career and an MBA. After 5-6 years in finance, you may just decide that you want to reset and start your own business or work in a sector that you enjoyed covering. You may decide you want a two year break before you go back to PE or whatever. For now at least, you don't want to get an MBA, thats fine. Nobody's going to force you to get one, and you can cross that bridge in another 3 years when you're deciding on what you want to do.

 
Most Helpful

Est omnis possimus autem quia sequi ut. Necessitatibus nemo similique ab.

Career Advancement Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.3%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.1%

Overall Employee Satisfaction

June 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Morgan Stanley 02 98.8%
  • Evercore 01 98.3%
  • BMO Capital Markets 12 97.7%
  • Banco Santander 01 97.1%

Professional Growth Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 05 98.3%
  • JPMorgan No 97.7%
  • Goldman Sachs 02 97.1%

Total Avg Compensation

June 2026 Investment Banking

  • Vice President (14) $434
  • Associates (44) $258
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (13) $156
  • 1st Year Analyst (79) $150
  • Intern/Summer Analyst (73) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
kanon's picture
kanon
99.0
3
Secyh62's picture
Secyh62
99.0
4
BankonBanking's picture
BankonBanking
99.0
5
dosk17's picture
dosk17
98.9
6
CompBanker's picture
CompBanker
98.9
7
GameTheory's picture
GameTheory
98.9
8
DrApeman's picture
DrApeman
98.9
9
Betsy Massar's picture
Betsy Massar
98.9
10
Linda Abraham's picture
Linda Abraham
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”